Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03502746
Brief Title: Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

First Submitted : April 11, 2018
First Submitted that Met QC Criteria : April 18, 2018
First Posted : April 19, 2018

Last Update Submitted that Met QC Criteria : August 15, 2019
Last Update Posted : August 16, 2019